Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ernexa Therapeutics Inc. | 3 | reported | 14 Jul 2021 | tx 4+3−75,000 |
| Comera Life Sciences Holdings, Inc. | 0 | reported | 29 Dec 2023 | tx 2+3,913,526 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Dec 2023 | PURCHASE | Comera Life Sciences Holdings, Inc. | — | 0.00 USD | derivfirst after silence |
| 29 Dec 2023 | PURCHASE | Comera Life Sciences Holdings, Inc. | 3,913,526 | 107622.00 USD | deriv |
| 14 Jul 2021 | PURCHASE | Ernexa Therapeutics Inc. | 1 | 11.99 USD | |
| 09 Jul 2021 | PURCHASE | Ernexa Therapeutics Inc. | 1 | 14.11 USD | |
| 06 Jul 2021 | SALE | Ernexa Therapeutics Inc. | 75,000 | 16.06 USD | |
| 08 Jul 2021 | PURCHASE | Ernexa Therapeutics Inc. | 1 | 14.35 USD |
1 purchase reported after at least 12 months of silence — most recent on 29 Dec 2023.